Rb Capital Management, LLC Moderna, Inc. Transaction History

Rb Capital Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	SELL	$135.66 - $197.02 $3,662 - $5,319	-27 Reduced 1.42%	1,872 $287,000
Q4 2022 Jan 10, 2023	SELL	$118.38 - $210.04 $35,514 - $63,012	-300 Reduced 13.64%	1,899 $341,000
Q3 2022 Oct 21, 2022	BUY	$118.07 - $194.18 $10,862 - $17,864	92 Added 4.37%	2,199 $260,000
Q2 2022 Jul 14, 2022	SELL	$117.13 - $176.59 $18,740 - $28,254	-160 Reduced 7.06%	2,107 $301,000
Q1 2022 Apr 11, 2022	BUY	$126.46 - $235.05 $19,980 - $37,137	158 Added 7.49%	2,267 $391,000
Q4 2021 Feb 14, 2022	BUY	$225.82 - $368.51 $32,518 - $53,065	144 Added 7.33%	2,109 $536,000
Q3 2021 Nov 12, 2021	BUY	$221.9 - $484.47 $10,429 - $22,770	47 Added 2.45%	1,965 $756,000
Q2 2021 Aug 06, 2021	BUY	$129.91 - $234.98 $249,167 - $450,691	1,918 New	1,918 $451,000

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Rb Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Rb Capital Management, LLC with notifications on news.